CareDx CEO to Present at CMS Panel Meeting on Monday, October 19 at 8:45am ET
BRISBANE, Calif., Oct. 18, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for …